Teradyne Agrees To Put $300 Million Into FormFactor Stock As The Two Test Makers Team Up
FormFactor will sell 2,234,887 new shares in a private placement alongside a collaboration on AI chips, packaging, memory and photonics.
FormFactor agreed to sell Teradyne 2,234,887 newly issued shares for aggregate cash of approximately $300.0 million, according to an 8-K filed Tuesday. The private placement comes with a broad technology collaboration between the two semiconductor test companies.
What the 8-K says
The Securities Purchase Agreement was signed October 6, and the companies announced the investment in a press release dated October 12. Teradyne is buying common stock with a $0.001 par value directly from FormFactor.
The shares are being issued under the Section 4(a)(2) exemption of the Securities Act of 1933, which covers private placements. The deal is expected to close in FormFactor's fourth quarter of fiscal 2026, subject to customary closing conditions. The press release adds that regulatory approvals are also required.
The release calls the purchase a $300 million strategic equity investment.
The collaboration behind the stock sale
The press release describes a technology collaboration to speed development, validation and high-volume production of next-generation chips. It names high-performance compute, advanced packaging, high-bandwidth memory and silicon photonics as target areas.
FormFactor would contribute probe, interface and test engineering expertise. Teradyne would bring its automated test platforms.
FormFactor CEO Mike Slessor said test performance, scalability and time-to-market are "becoming decisive competitive advantages." Teradyne President and CEO Gregory Smith said the hardest test problems in packaging, photonics and memory "can't be solved by a single company."
The companies also expect the tie-up to widen joint customer engagement.
What it changes for holders
If you own FormFactor, the share count will rise by the 2,234,887 shares once the sale closes, and Teradyne becomes a holder. FormFactor shares closed at $130.28 at Monday's close, down 6.72% on the session, before the filing was public.
The next marker is the closing of Teradyne's purchase, which the 8-K places in FormFactor's fourth quarter of fiscal 2026.
Sources
- 8-K Filing — FORMFACTOR INC (FORM) — SEC EDGAR
- Exhibit ex-991.htm — FORMFACTOR INC 8-K exhibit — SEC EDGAR
- FormFactor and Teradyne Announce Strategic Collaboration to — globenewswire.com